Company intelligence / Profile preview

Indian Immunologicals Limited

Hyderabad, Telangana, Indiaindimmune.com ↗
Ownership
Private
Development stage
Other
01

Overview

IIL is a major supplier of vaccines to India's Universal Immunization Programme and exports to over 50 countries. It is the largest producer of anti-rabies vaccines in the world.

Therapeutic areas
Infectious Diseases
Modalities
VaccinesBiologicals
Industry
Biotech
02

Drug pipeline

22 assets

anti-rabies monoclonal antibodies (Indian Immunologicals)

4

21 more assets in the full pipeline.

03

Partnerships

Polyvac Institute (Vietnam)Griffith University (Australia)

Beyond the preview

Go deeper on Indian Immunologicals Limited.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Indian Immunologicals Limited.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call